NASDAQ:RAIN Investor Notice: Lawsuit Alleges False and Misleading Statements by Rain Oncology Inc.
An investor, who purchased shares of Rain Oncology Inc. (NASDAQ:RAIN), filed a lawsuit over alleged violations of Federal Securities Laws by Rain Oncology Inc. in connection with certain allegedly false and misleading statements.
View full press release